Arcutis Biotherapeutics (ARQT) Net Income by Year
Arcutis Biotherapeutics, Inc. reported a net loss of $16.1M in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $28.5M in net income. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters Arcutis Biotherapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ARQT Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
ARQT Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Arcutis Biotherapeutics, Inc. financials
Frequently Asked Questions
What was Arcutis Biotherapeutics, Inc.'s net income in fiscal year 2025?
Arcutis Biotherapeutics, Inc. reported a net loss of $16.1M in fiscal year 2025.
How fast is Arcutis Biotherapeutics, Inc.'s net income growing?
Arcutis Biotherapeutics, Inc. (ARQT) reported a $140.0M net loss in fiscal year 2024 and a $16.1M net loss in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.
What is Arcutis Biotherapeutics, Inc.'s net income over the last twelve months?
Arcutis Biotherapeutics, Inc. (ARQT) reported $28.5M in net income over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has Arcutis Biotherapeutics, Inc.'s net income changed over the years?
Across the 8 fiscal years this page covers, Arcutis Biotherapeutics, Inc. (ARQT) net income went from -$19.3M in fiscal year 2018 to -$16.1M in fiscal year 2025.
What was Arcutis Biotherapeutics, Inc.'s net income in the most recent quarter?
Arcutis Biotherapeutics, Inc. (ARQT) reported $15.0M in net income in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Arcutis Biotherapeutics, Inc. (ARQT) reported on that line in every period on record.